114 related articles for article (PubMed ID: 34275891)
1. Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
Khorshied M; Soliman N; Khorshid O; Bakr S
Cancer Biomark; 2021; 32(4):451-458. PubMed ID: 34275891
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
[TBL] [Abstract][Full Text] [Related]
3. TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.
Chen B; Liu S; Wang XL; Xu W; Li Y; Zhao WH; Wu JQ
Eur J Cancer; 2009 Sep; 45(14):2598-605. PubMed ID: 19643596
[TBL] [Abstract][Full Text] [Related]
4. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
[TBL] [Abstract][Full Text] [Related]
5. Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.
Chen W; Tang WR; Zhang M; Chang K; Wei YL
Asian Pac J Cancer Prev; 2014; 15(6):2889-92. PubMed ID: 24761920
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
[TBL] [Abstract][Full Text] [Related]
9. Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis.
Lu J; Qin Q; Zhan LL; Liu J; Zhu HC; Zhang C; Xu LP; Liu ZM; Yang X; Cheng HY; Sun XC
Tumour Biol; 2014 Jun; 35(6):5149-58. PubMed ID: 24492941
[TBL] [Abstract][Full Text] [Related]
10. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).
Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N
Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959
[TBL] [Abstract][Full Text] [Related]
11. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
12. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
[TBL] [Abstract][Full Text] [Related]
13. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
[TBL] [Abstract][Full Text] [Related]
14. Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.
Khorshied MM; Gouda HM; Khorshid OM
Leuk Lymphoma; 2014 May; 55(5):1061-6. PubMed ID: 23829277
[TBL] [Abstract][Full Text] [Related]
15. A study of TRAIL receptors in squamous cell carcinoma of the head and neck.
Teng MS; Brandwein-Gensler MS; Teixeira MS; Martignetti JA; Duffey DC
Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):407-12. PubMed ID: 15897419
[TBL] [Abstract][Full Text] [Related]
16. TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.
Körner C; Riesner K; Krämer B; Eisenhardt M; Glässner A; Wolter F; Berg T; Müller T; Sauerbruch T; Nattermann J; Spengler U; Nischalke HD
BMC Cancer; 2012 Mar; 12():85. PubMed ID: 22401174
[TBL] [Abstract][Full Text] [Related]
17. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
18. Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms.
Fernàndez V; Jares P; Beà S; Salaverria I; Guino E; de Sanjosé S; Colomer D; Ott G; Montserrat E; Campo E
Haematologica; 2004 Nov; 89(11):1322-31. PubMed ID: 15531454
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.
Rubio-Moscardo F; Blesa D; Mestre C; Siebert R; Balasas T; Benito A; Rosenwald A; Climent J; Martinez JI; Schilhabel M; Karran EL; Gesk S; Esteller M; deLeeuw R; Staudt LM; Fernandez-Luna JL; Pinkel D; Dyer MJ; Martinez-Climent JA
Blood; 2005 Nov; 106(9):3214-22. PubMed ID: 16051735
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.
Zahoor A; Mansoor Q; Farooqi AA; Fayyaz S; Naz G; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):108-12. PubMed ID: 26518902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]